CureVac N.V. is a biotechnology company focused on developing transformative therapeutics based on its proprietary mRNA technology platform

The company aims to create innovative treatments for various diseases, including cancers and infectious diseases, by harnessing the power of messenger RNA to instruct cells to produce proteins that can elicit a therapeutic effect. CureVac is committed to advancing its vaccine candidates and therapies through rigorous research and clinical trials, striving to deliver next-generation solutions for patients in need of advanced medical treatments.